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Recently, the expression of the peptide hormone ghrelin was detected in a-cells of the islets of Langerhans as well as in q-cells, a newly
discovered endocrine cell type, but it remains unclear how the latter is related in lineage to the four classical islet cell types, a-, h-, y-, and PP-
cells. Here, we provide further evidence that ghrelin is predominantly produced in the a-cells of mouse islets but also in single hormone
ghrelin-secreting q-cells. We additionally demonstrate that pancreatic q-cells derive from Neurogenin3-expressing precursor cells and their
genesis depends on Neurogenin3 activity. Furthermore, our data indicate that the number of ghrelin-producing cells is differentially regulated
during pancreas morphogenesis by the homeodomain-containing transcription factors Arx, Pax4, and Pax6. Arx mutants lack ghrelin+
glucagon+ a-cells whereas Pax4 mutants develop an excess of these cells. Importantly, the ghrelin+ glucagon q-cell population is not
affected following Arx or Pax4 disruption. In contrast, the loss of Pax6 provokes an unexpected increase of the ghrelin+ glucagon q-cell
number which is not due to increased proliferation. Thus, we demonstrate that the development of ghrelin-producing cells is differentially
dependent on Neurogenin3 in different domains of the gastrointestinal tract and that, in the endocrine pancreas, q-cell genesis does not require
Arx or Pax4 activities but is antagonized by Pax6.
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Pancreatic endocrine cells are located in clusters known as
islets of Langerhans. These islets, classically described as
micro-organs, possess four different endocrine subtypes:
glucagon-producing a-cells, insulin-expressing h-cells,
somatostatin-secreting y-cells, and pancreatic polypeptide-
producing PP-cells. Endocrine cells appear in the developing
mouse pancreas at embryonic day (E) 9.5 (Upchurch et al.,0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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NIH Beta Cell Biology Consortium.1994). Insulin immunoreactive cells differentiate 1 day later,
at E10.5, and these frequently co-express glucagon (Teitel-
man et al., 1993), but lack the expression of a critical
transcription factor, Pdx1, normally present in mature h-
cells at birth (Jensen et al., 1996, 2000; Ohlsson et al.,
1993). Around E13.5, the so-called ‘‘secondary transition’’,
leads to a peak of a- and h-cell formation (Pictet and Rutter,
1972) concurrently with the generation of Pdx1+ h-cells.
Finally, y- and PP-cells develop around E15 and E18,
respectively (Pictet and Rutter, 1972). Recent reports
suggest that ghrelin, a growth hormone-releasing and
orexigenic peptide originally characterized in enteroendo-
crine cells of the G-I tract, is also secreted in the pancreas by
a new islet cell type, the q-cell (Prado et al., 2004; Wierup
et al., 2004).286 (2005) 217 – 224
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for their involvement in endocrine pancreas development.
Among those, the bHLH protein Neurogenin3 (Ngn3)
represents a common marker of the enteroendocrine cell
lineage required for the formation of all intestinal and
pancreatic endocrine cells (Gradwohl et al., 2000; Gu et al.,
2002; Herrera, 2002; Jenny et al., 2002). Notably, in gastric
tissues, despite its expression in the precursors of the
glucagon-, somatostatin-, ghrelin-, histamine-, and seroto-
nin-producing cells, Ngn3 is required uniquely for the
formation of glucagon-, gastrin-, and somatostatin-produc-
ing cells (Jenny et al., 2002; Lee et al., 2002). In contrast,
Ngn3 function is absolutely necessary for the genesis of
intestinal and pancreatic endocrine tissues (Gradwohl et al.,
2000; Jenny et al., 2002). Following Ngn3 activation,
several downstream factors were characterized for their key
role in endocrine subtype specification in the pancreas,
intestine, and/or stomach, including the homeodomain-
containing proteins Pax4, Pax6, Arx, Nkx2.2, and Nkx6.1
(Collombat et al., 2003; Larsson et al., 1998; Sander et al.,
1997, 2000; Sosa-Pineda et al., 1997; St-Onge et al., 1997;
Sussel et al., 1998). Pax4 promotes the genesis of virtually
all duodenal hormone-secreting cells as well as serotonin+
and somatostatin+ cells of the distal stomach, whereas Pax6
acts in the development of duodenal GIP+ (gastric inhibitory
polypeptide) cells, and of gastrin+ and somatostatin+ cells of
the distal stomach (Larsson et al., 1998). Additionally, both
Pax4 and Pax6 regulate pancreatic endocrine development:
Pax4 mutant mice lack h- and y-cells but display an
increased number of a-cells (Sosa-Pineda et al., 1997)
whereas Pax6-depleted mice exhibit reduced numbers of all
four classical islet cell types and present a diminished
transcription of the corresponding hormone genes (Heller et
al., 2004; Sander et al., 1997; St-Onge et al., 1997).
Similarly, the homeodomain-containing protein Arx was
recently demonstrated to act downstream of Ngn3 and to be
required for a-cell fate specification (Collombat et al.,
2003). Arx-deficient mice lack a-cells at birth and display a
concomitant increase in h- and y-cell numbers. Interestingly,
Arx and Pax4 mutant animals exhibit opposite phenotypes
in relation to a-, h-, and y-cell development possibly due to
mutual cross-repressive interactions between these genes
(Collombat et al., 2003). Using a loss-of-function approach,
the role of additional homeodomain-containing factors in
pancreatic endocrine specification has been unraveled.
Notably, mice deficient for Nkx2.2 lack h-cells and possess
fewer a- and PP-cells, while y-cells are not affected (Sussel
et al., 1998). The islets of Nkx2.2-deficient mice comprise a
large number of cells that do not produce any of the classical
islet hormones. Further studies indicate that the distantly
related factor Nkx6.1, required for normal h-cell develop-
ment, acts downstream of Nkx2.2 in the endocrine differ-
entiation processes (Sander et al., 2000).
Little is known regarding the transcription factors that
govern formation of ghrelin-producing cells in the islets. In
human pancreas, ghrelin has been noted for its co-detectionwith either glucagon (Date et al., 2002) or insulin (Volante et
al., 2002), whereas other investigators were unable to detect
ghrelin expression within any of the four classical islet cell
types (Wierup et al., 2002), indicating that a fifth islet cell type
might exist. Sussel and co-workers demonstrated that inmice,
ghrelin is produced by a-cells as well as by q-cells (Prado et
al., 2004). Moreover, this study provides evidence that in
animals lacking Nkx2.2 (Sussel et al., 1998) and Pax4 (Sosa-
Pineda et al., 1997), q-cells are formed in place of h-cells.
In the present report, we characterized pancreatic ghrelin-
producing cells throughout pancreas morphogenesis in
relation to other endocrine hormones and lineage-associated
transcription factors. Specifically, the function of the Ngn3,
Arx, Pax4, and Pax6 genes in the ghrelin-producing cell
specification processes was genetically examined. A short-
term lineage tracing demonstrates that q-cells derive from
Ngn3-expressing precursors whereas the analysis of Ngn3-
deficient mice indicates that the development of q-cells
depends on Ngn3 activity. Finally, our study reveals that the
Arx and Pax4 genes do not regulate q-cell numbers while
Pax6 antagonize the formation of q-cells.Materials and methods
Tissue preparation
Mouse pancreata were isolated from embryonic days 10,
12, 14, 18, P5, P10, and 3-, 6- and 16-week-old animals and
immediately fixed in cold 4% PFA overnight. Tissue was
embedded in paraffin and 4-Am sections were cut onto glass
slides.
Ghrelin monoclonal antibody production
A synthetic peptide carrying an octanoyl acid on ser 3
(GSSFLSPEHQRVQQRKES) corresponding to 18 residues
located in the N-terminal domain of the human ghrelin
peptide was used as antigen to raise the monoclonal
antibody 1D7. An additional C-terminal cysteine was added
for the coupling to ovalbumin. The method used for
antibody production was as previously described (Moog-
Lutz et al., 1997). The antibody recognizes both octanoy-
lated and non-octanoylated forms of ghrelin on Western blot
and by competition studies it displayed a higher affinity for
the non-modified form (data not shown).
Immunohistochemistry
Immunohistochemistry was performed as previously
described (Collombat et al., 2003; Gradwohl et al., 2000;
Jensen et al., 1996). Briefly, paraffin sections were dewaxed
in xylene and rehydrated through descending ethanol series.
Antigen retrieval was accomplished through microwave
treatment (600 W for 4 min followed by 15 min at 250 W in
10 mM Tris–EGTA buffer, pH 9.0) followed by three
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used: briefly, the sections were blocked for non-specific
binding of the antisera during 30 min at room temperature
using TNB buffer, followed by 10% donkey non-immune
serum for 10 min. Primary antisera (see Table for dilutions)
were added overnight at room temperature followed by
three washes in PBS. To test the specificity of the ghrelin
antiserum, tissues were preincubated with 5 Ag of ghrelin
peptide or an irrelevant peptide derived from Notch-1. An
anti-rabbit biotinylated secondary antibody (Zymed) was
next added for 30 min, followed by three washes in PBS.
The sections were then incubated with a streptavidin-
peroxidase antiserum (Zymed) for 15 min and rinsed three
times in PBS. Tyramide-Cy3 (Perkin and Elmer) was diluted
1:100 and added for exactly 10 min, and followed by three
washes in PBS. Finally, the secondary anti-Cy-2, -Cy-3, or
-Cy-5 antiserum (Jackson ImmunoResearch) were incubated
with the tissues for 30 min. Following three washes in PBS,
the slides were mounted with Fluorescent mounting media
(Kirkegaard and Perry). Images were collected with an
Olympus BX51 microscope, captured using a Hamamatsu
C5810 cooled CCD camera and Image Pro Plus 4.5 software
interfaced with a PC computer or by confocal microscopy
using a Zeiss LSM510 Meta.
Mouse strains
Ngn3, Arx, and Pax4 mutant mice were bred and
maintained as previously described (Collombat et al.,
2003; Gradwohl et al., 2000; Sosa-Pineda et al., 1997).
Pancreata from day E15, E18, and post-natal day 1 mice
were fixed in 4% PFA at 4-C for 2 h, rinsed and equilibrated
in 30% sucrose in PBS at 4-C for 12 h, mounted in Tissue-
Tek (Sakura), frozen on dry ice, cut, and processed for
immunocytochemistry. Small eye (Pax6 mutant) mice (Hill
et al., 1991) were obtained from Dr. Veronica van
Heyningen (Edinburgh, Scotland) and were bred at M&B
A/S, Ry, Denmark.Antigen Species Dilution Source
h-galactosidase Mouse 1:7500 Promega
Brn4 Rabbit 1:2000 M. Geoff Rosenfeld, UCSD, San
Diego, CA
Pdx1 253 Rabbit 1:5000 Joel Habener, MGH, Boston, MA
Pax6 Rabbit 1:2000 Babco, Richmond, CA
Nkx2.2 Rabbit 1:2000 Thomas Jessell, Columbia Univ.
New York
Nkx6.1 Rabbit 1:5000 Jensen et al., 1996
ISL-1 Rabbit 1:1000 Helena Edlund, Umea˚, Sweden
Insulin Mouse 1:75 Novo Nordisk A/S, Denmark
Insulin Guinea pig 1:200 DAKO, Glostrup, Denmark
Glucagon Mouse 1:50 Novo Nordisk A/S, Denmark
PP Rabbit 1:500 DAKO, Glostrup, Denmark
Somatostatin Mouse 1:10 Novo Nordisk A/S, Denmark
Ghrelin Goat 1:500 Santa Cruz Biotechnology, CA
Ghrelin Mouse 1:1500 Catherine Tomasetto, IGBMC,
Strasbourg
Ghrelin1882 Rabbit 1:1500 Tomasetto et al., 2000Cell quantitation and data analysis
Double immunostaining for ghrelin and glucagon was
performed on cryosections. The number of single ghrelin-
positive cells and ghrelin-glucagon-double-positive cells
was counted and expressed as a percentage of the total
ghrelin-positive cells on the sections at different embryonic
stages. The quantitation of the number of ghrelin cells in the
Pax6 mutant mice was performed as follows. The total
pancreatic area and total number of ghrelin cells were
counted on at least 6 sections from three different animals.
The data are expressed as the number of ghrelin cells/mm2
pancreas tissue. Ghrelin cells in the Arx and Pax4 mice were
quantitated as previously described (Collombat et al., 2003).
Results are expressed as mean T SEM. Mean changes were
compared using the Students t test. P < 0.05 was considered
to be statistically significant.Results
Ghrelin is expressed in a-cells but also as a unique
hormone-producing cell type in the mouse islets
To determine whether the ghrelin hormone is expressed
in one or more of the four classical endocrine cell
subtypes in the mouse pancreas, we performed double
immunohistochemical stainings on E18.5 pancreatic sec-
tions using an antiserum raised against ghrelin, combined
with antisera against glucagon, insulin, somatostatin, or
pancreatic polypeptide, labeling a-, h-, y-, or PP-cells,
respectively. Consistent with previous findings (Prado
et al., 2004), our results demonstrate a clear co-local-
ization of ghrelin with glucagon, but also uncover the
presence of cells uniquely immunoreactive for ghrelin
(Fig. 1A). The absence of co-localization of ghrelin with
insulin (Fig. 1B), somatostatin (Fig. 1C), or PP (Fig. 1D)
indicates that these ghrelin+ glucagon cells represent a
distinct pancreatic endocrine cell type. Identical results
were obtained using three different ghrelin antisera (data
not shown). To further demonstrate the presence of
ghrelin+ cells lacking the four classical islet hormones, a
dual labeling was performed using a ghrelin antiserum in
combination with glucagon, insulin, somatostatin, and PP
antisera. Consistent with our previous results, several
ghrelin immunoreactive cells negative for all four other
hormones were observed (Fig. 1E). Double immunocy-
tochemistry for ghrelin and gastrin or PYY showed that
these two did not co-localize at E15 (data not shown). At
2 weeks of age and later, ghrelin immunoreactivity was
not detected in mouse pancreas (data not shown). Hence,
our data confirm and extend the findings of Prado et al.
that in the mouse endocrine pancreas, ghrelin peptide
expression is detectable in a-cells but also in a single-
hormone ghrelin-secreting cell subtype, which we refer to
as q-cells.
Fig. 1. Analysis of ghrelin immunoreactivity in E18.5 mouse pancreas. (A)
The glucagon and ghrelin hormones are co-detected in a subset of islet
cells. (B–E) Ghrelin is not co-secreted with the insulin (B), somatostatin
(C) or pancreatic polypeptide (D) hormones. (E) Ghrelin+ cells devoid of
any of the classical islet hormones are clearly detectable. Arrows point to
examples of ghrelin single positive cells and arrowheads designate
examples of cell co-expressing ghrelin and the indicated marker. Scale
bar is 30 Am.
Fig. 2. Ngn3 is required for pancreatic ghrelin expression in mice. (A–C)
At E10.5, most ghrelin-secreting cells produce glucagon in control animals
(A, B) whereas these cells are lacking in Ngn3 mutant mice (C). (D–F) At
E15.5, a majority of ghrelin immunoreactive cells do not express glucagon,
while most glucagon-expressing cells are immunoreactive for ghrelin in
wild-type mice (D–E); both cell types are deficient in Ngn3 mutant mice
(F). (G–L) At E18.5 (G–I) and P1 (J–L), three populations of cells in
wild-type mice are detectable: cells uniquely expressing either ghrelin or
glucagon and cells producing both hormones (G, H, J, K). None of these
populations are found in Ngn3 mutants (I, L). A lineage analysis of ghrelin
and glucagon-producing cells indicates that both populations derive from
cells expressing the GFP marker under the control of the Ngn3 promoter
(M–P). Arrowhead points to an example of a GFP/ghrelin/glucagon triple
positive a-cell and the arrow (MV–PV) designates an example of an q-cell
co-expressing GFP and ghrelin but not glucagon. Scale bar is 30 Am.
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from Ngn3-expressing precursors
To decipher the molecular mechanisms regulating the
genesis of ghrelin- and glucagon-secreting cells in embry-
onic and early post-natal pancreas, we examined both cell
types in wild-type and Ngn3-deficient mice (Gradwohl et
al., 2000). In control animals, our results confirm that
throughout normal embryonic and early post-natal develop-
ment (from E10.5 to P1), ghrelin is often co-detected with
glucagon, but also clearly establish the presence of ghrelin+
glucagon q-cells (Fig. 2; Table 1). Importantly, the analysis
of Ngn3-deficient mice reveals that ghrelin expression in the
pancreas requires Ngn3 function at all stages examined (Fig.
2), indicating that ghrelin+ q-cells in the pancreas share a
common lineage with the four classical endocrine cells. To
shed light upon the relationship between Ngn3-expressing
progenitors and q-cells, we performed short-term lineage
tracing experiments using mice expressing the GFP marker
under the control of Ngn3 regulatory sequences created in
the same way as the Ngn-3-YFP mice (Mellitzer et al.,
2004). Since mature hormone-expressing cells do not
express Ngn3 and Ngn3-positive cells are not observed toexpress hormones (Gradwohl et al., 2000; Jensen et al.,
2000), detection of co-localized GFP and ghrelin will
indicate that ghrelin+ cells are derived from cells previously
expressing ngn3 but with GFP still being present due to the
longer half-life of GFP compared to NGN3. Triple staining
Table 1
Relative proportions of ghrelin-producing cells throughout pancreas
development
% Single Ghr+
cells/total
Ghr+ cells
% Ghr+ Glu+
cells/total
Ghr+ cells
E10.5 (n = 38) 5 95
E15.5 (n = 211) 30 70
E18.5 (n = 260) 25 75
P1 (n = 114) 8 92
Numbers are provided as percent of single-hormone ghrelin+ cells and
double-hormone ghrelin+ glucagon+ cells in relation to the total population
of ghrelin+ immunoreactive cells.
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strates the existence of both GFP+ ghrelin glucagon+ and
GFP+ ghrelin+ glucagon+ a-cells (Figs. 2M–P), as well as
GFP+ ghrelin+ glucagon q-cells (Figs. 2MV–PV), providing
further evidence that q-cells, like the other four islet cell
types, arise from Ngn3-expressing precursors. Not all
ghrelin+ cells contained GFP consistent with the notion that
only short-term lineage tracing is possible using this system.
Arx and Pax4 differentially regulate ghrelin expression
The Arx and Pax4 genes have recently been shown to
play opposite roles in specifying a- versus h- and y-cell
fates during pancreas ontogeny (Collombat et al., 2003). In
order to determine whether the Arx deficiency, resulting in
the lack of mature a-cells, would also promote the loss ofFig. 3. Arx and Pax4 exhibit differential roles in ghrelin-producing cell generation.
(A–J) and anti-h-galactosidase antisera (A, B) and counterstained with DAPI (A–
reporter gene in the Pax4 or Arx gene locus present both in Arx and Pax4 heterozy
data were further confirmed using an anti-Arx antibody (data not shown). Arx defi
and I), although ghrelin+ glucagon cells remain. The loss of a Pax4 functional
ghrelin+ glucagon+ cell population without affecting the ghrelin+ glucagon popul
litters. Scale bar is 30 Am.ghrelin expression, Arx loss-of-function and control mice
were examined for the presence of ghrelin- and glucagon-
producing cells. Our findings demonstrate that the ghrelin+
glucagon+ a-cell population is drastically reduced in Arx
mutants (Figs. 3A, C, E, G, I and Table 2). However,
ghrelin+ glucagon q-cells are still present in Arx mutant
pancreas (Figs. 3E, I) and the quantitative data indicate that
the number of these cells is not statistically different from
the amount of ghrelin+ glucagon q-cells observed in
control mice, suggesting that q-cells are not affected by
the Arx deletion (Table 2). To verify this assumption, Pax4
mutant pancreas, characterized by an increase of the Arx
transcript content associated with a loss of h- and y-cells
concomitantly with an augmentation of the a-cell popula-
tion, were also assayed (Collombat et al., 2003; Sosa-Pineda
et al., 1997). A striking increase of the ghrelin+ glucagon+
a-cell population was detected as compared to controls
while the number of ghrelin+ glucagon q-cells was again
found unchanged (Figs. 3B, D, F, H, J, and Table 2). Hence,
these data are consistent with the notion that Arx and Pax4
are both required for the proper a-cell fate specification but
not for the q-cell destiny.
Pax6-deficient mice develop an excess of ghrelin-producing
e-cells
Nkx2.2-deficient mice were recently reported to have
increased numbers of ghrelin+ cells (Prado et al., 2004). The
reduced Pax6 expression levels exhibited by these mutantExamination of E15 (A–F) and P0 (G–J) sections stained with anti-ghrelin
J) reveals that the ghrelin peptide is co-expressed with the b-galactosidase
gous mice (arrows in panels A and B, respectively). In the case of Arx, these
ciency is characterized by an early-onset loss of ghrelin+ glucagon + cells (E
allele produces the opposite phenotype leading to an early increase of the
ation (F and J). Each picture is representative of 3–6 animals from different
Table 2
Quantification of the alterations in pancreatic ghrelin-producing cell
numbers following Arx or Pax4 deletions
Ghrelin+ glucagon
q-cells
Ghrelin+ glucagon+
a-cells
E15.5 WT 15 T 7 35 T 12
E15.5 Arx/ 9 T 5 0
E15.5 Pax4/ 23 T 12 89 T 17 (+254%)
P0 WT 26 T 9 153 T 19
P0 Arx/ 21 T 8 0
P0 Pax4/ 35 T 11 359 T 26 (+235%)
Ghrelin+ glucagon q-cells and ghrelin+ glucagon+ a-cells were counted on
immunostained sections of E15 and P0 serially cut pancreas estimated to be
of the same size. Data are shown as the mean number T standard error of the
mean (SEM) of hormone-positive cells per section (every fifth section)
from at least three independent pancreata. As early as E15.5, a-cells lack in
Arx mutant pancreas, whereas twice more are detectable following Pax4
disruption, as compared to controls. Interestingly, the q-cell population is
not altered following Arx or Pax4 deletion.
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represent a target of Nkx2.2 inhibiting ghrelin cell genesis.
We therefore examined the ghrelin-producing cell popula-
tion in Pax6sey/sey mice which have a spontaneous mutation
in the Pax6 gene (Hill et al., 1991). In accordance with our
assumption, E19 Pax6sey/sey mutant embryos displayed an
excess of ghrelin-expressing cells (Fig. 4) whereas the
glucagon-producing a-cell population was drastically
reduced as previously reported (Heller et al., 2004; Sander
et al., 1997; St-Onge et al., 1997). A quantification of the
number of ghrelin+ cells in sections of wild-type and Pax6
mutant pancreas revealed that wild-type mice possessed 8 T
6 ghrelin+ cells/mm2 of pancreas tissue, while Pax6sey/sey
mutants display 45 T 13 ghrelin+ cells/mm2 pancreas tissueFig. 4. Pax6 regulates the generation but not the proliferation of ghrelin-secretin
expression is lacking in most ghrelin- and glucagon-secreting cells in both wild-typ
cells including the q-cells are Isl1 positive. (D, H) The q-cell population is post-mi
Ki67, a marker of proliferating cells. Arrows point to examples of ghrelin+ gluca(P < 0.01, n = 3), representing a more than 5-fold increase
in the total ghrelin+ cell number. It is important to note that
most of the ghrelin+ cells found in E19 Pax6sey/sey pancreas
do not express glucagon or any of the other three classical
islet hormones, suggesting that they correspond to q-cells
(Fig. 4, and data not shown), nor do they express the h-cell
markers Pdx1 and Nkx6.1 (Fig. 4). In order to address if the
increased number of ghrelin+ glucagon cells seen in the
Pax6 mutant were due to increased proliferation of these
cells, we analyzed the expression of Ki67, a marker of
proliferating cells in wild-type and mutant mice. We find
that in both wild-type and mutant mice, the q-cell population
is post-mitotic (Figs. 4D, H). Taken together, these data
indicate that the lack of a functional Pax6 allele promotes
the formation of q-cells.Discussion
Ghrelin, a peptide hormone originally characterized in
gastric tissues (Kojima et al., 1999; Tomasetto et al., 2000),
is also present in the mouse pancreatic islets. Here, we
provide definitive evidence that the ghrelin hormone is
synthesized by the glucagon-producing cell population.
However, our study also confirmed the presence of single-
hormone ghrelin-producing cells devoid of any of the four
classical islet hormones, termed q-cells (Prado et al., 2004).
Intriguingly, these findings contrast with those reported by
Volante et al. (2002) displaying a co-localization of ghrelin
with insulin in human pancreas. The reason for this
discrepancy remains unclear but could originate in the
different staining procedures. Our results demonstrating theg cells in the mouse endocrine pancreas. Nkx6.1 (A, E) and Pdx1 (B, F)
e (A, B) and Pax6 mutant (D, E) mice. (C, G) All hormone immunoreactive
totic in both wild-type and mutant mice as demonstrated by examination for
gon cells and arrowheads indicate ghrelin+ a-cells. Scale bars are 30 Am.
R.S. Heller et al. / Developmental Biology 286 (2005) 217–224 223absence of cells co-producing ghrelin with insulin proteins
or the h-cell-specific transcription factors Pdx-1 and Nkx6.1
clearly establish that mouse h-cells do not express the
ghrelin peptide.
The analysis of mice deficient for Ngn3 as well as
animals driving the expression of the GFP reporter gene
under the control of the Ngn3 promoter demonstrates that q-
cells, as other islet cell types, derive from Ngn3-expressing
precursors and are fully dependant on Ngn3 activity
(Gradwohl et al., 2000; Gu et al., 2002; Herrera, 2002).
Interestingly, the fact that the ghrelin+ cells in the stomach
develop independently of Ngn3 (Jenny et al., 2002) under-
scores the existence of two independent mechanisms in the
G-I tract that leads to ghrelin-producing cells: the first one
necessitates Ngn3 activity in the endocrine pancreas while
the other in the stomach does not depend on Ngn3. Aiming
to further characterize the factors acting in the q-fate
specification, we undertook an analysis of this population
in animals deficient for several Ngn3-dependent genes that
have been demonstrated as key factors in endocrine cell
specification (Collombat et al., 2003; Sander et al., 1997;
Sosa-Pineda et al., 1997; St-Onge et al., 1997). Our data
demonstrate that in the absence of a functional Arx allele, a
drastic reduction in the total number of ghrelin+ cells occurs.
As Arx is indispensable for the a-cell fate specification and
antagonizes h- and y-cell formation (Collombat et al.,
2003), such a decrease in ghrelin+ cells can easily be
attributed to the loss of ghrelin+ glucagon+ a-cells.
Similarly, the large expansion of the ghrelin+ cells found
in Pax4 mutant mice suggests that the cells normally fated
towards a h- and/or y-cell fate adopt an alternative ghrelin+
glucagon+ a-cell destiny. Importantly, the numbers of
pancreatic ghrelin+ glucagon q-cells appear unchanged
following Arx or Pax4 depletion as compared to wild-type
pancreas, suggesting that unlike a-cells, q-cells develop
independently from both factors. Additionally, it was
recently reported that Foxa2 is required for the a- but not
the q-cell lineage (Lee et al., 2005). This latter result also
establishes that q-cells have an a-cell independent origin.
Along the same line of evidence, the increase in the q-cell
content concomitant with the loss of the a-cell population
observed in Pax6 mutants confirms that a- and q-cells
represent distinct endocrine cell types subjected to different
regulatory signals.
Taken together, our data indicate that pancreatic ghrelin-
producing q-cells derive from Ngn3-expressing precursors
and require Ngn3 function. We demonstrate that both Arx
and Pax4 factors regulate the a-cell destiny but do not act on
the q-cell specification. On the contrary, Pax6 appears to
play a key role in determining the q-cell fate for endocrine
precursors since its ablation promotes a striking augmenta-
tion of the q-cell population at the expense of the other cell
types. Sussel and co-workers have also reported excess
numbers of ghrelin-producing cells in mice deficient for
Nkx2.2 (Prado et al., 2004). Based on these observations,
together with the loss of Pax6 expression detected inNkx2.2/ animals (Wang et al., 2004) and the unaffected
Nkx2.2 expression levels exhibited by Pax6sey/sey mice
(Heller et al., 2004), we propose that Pax6 represents a
downstream target of Nkx2.2 in pathways leading to the
pancreatic ghrelin-secreting q-cell fate.Acknowledgments
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